by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital
A strong Swiss franc, one of the landmark byproducts of the eurozone debt crisis, appears finally to be unwinding. It is more significant than just being a foreign-exchange trade.
by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Shares of FibroGen are soaring more than 50 percent in pre-market trading Tuesday after the biotech reported positive study results for a potential blockbuster drug. The biotech company’s drug pamrevlumab, a treatment for fatal lung disease idiopathic pulmonary...
by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
President Donald Trump can’t seem to break out of his polling funk. Trump’s approval ratings in three new polls fail to crack 40 percent. A CNN poll out late Monday showed 38 percent of Americans approve of the job the president is doing versus 56 percent...
by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
The hottest new trend in smartphones is right in front of you. Started by Samsung and quickly followed by others including LG, Essential and, as of Tuesday, Sharp, smartphones are beginning to pack screens that take up almost the entire front of the phone....
by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
No more money on the table? Ask if you can adjust your title to be slightly more senior — or at the very least, slightly more in line with your job function. See if you can swap words like “coordinator” for “manager,” or...
by synergycap1 | Aug 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
ZURICH (Reuters) – Following a formula pioneered by their corporate raider father-in-law, two men are stirring up the chemicals sector with a push to halt Clariant’s $20 billion merger with Huntsman. Known as the “two Davids”, David Winter and...
